Sara Fancelli

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Post-operative outcomes of lung resection after perioperative chemoimmunotherapy for stage IIB-IIIB non-small-cell lung cancer in the elderly: a single center real-life experience.

Post-operative outcomes of lung resection after perioperative chemoimmunotherapy for stage IIB-IIIB non-small-cell lung cancer in the elderly: a single center real-life experience.

Journal: Journal of thoracic disease

Published: October 07, 2025

KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC.

KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC.

Journal: Frontiers in oncology

Published: June 26, 2025

Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration.

Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration.

Journal: Frontiers in oncology

Published: April 17, 2025

Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma.

Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma.

Journal: Anti-cancer drugs

Published: August 09, 2024

Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors.

Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors.

Journal: Scientific reports

Published: June 26, 2024

Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy.

Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy.

Journal: Oncology research

Published: January 29, 2024

Unconventional strategy could be the future: From target to KRAS broad range treatment.

Unconventional strategy could be the future: From target to KRAS broad range treatment.

Journal: Heliyon

Published: September 28, 2023

Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer.

Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer.

Journal: Anti-cancer drugs

Published: February 02, 2023

Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.

Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.

Journal: International journal of molecular sciences

Published: January 26, 2023

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Journal: Journal of the National Cancer Institute

Published: November 08, 2022

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.

Journal: Frontiers in oncology

Published: September 27, 2022

Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.

Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 31, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026